Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease
Status:
Suspended
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The study is designed to determine if high doses of intravenous ascorbic acid (vitamin C) can
be effective in managing solid tumor diseases. Secondary goals are determination of any
palliative effects and improvement of quality of life of patients.